ADVANCED CELL TECHNOLOGY, INC. 4
4 · ADVANCED CELL TECHNOLOGY, INC. · Filed Sep 4, 2014
Insider Transaction Report
Form 4
Lanza Robert
Chief Scientific Officer
Transactions
- Sale
Common Stock
2014-09-02$8.12/sh−10,000$81,200→ 214,439 total - Sale
Common Stock
2014-09-03$9.00/sh−10,000$90,000→ 199,439 total - Sale
Common Stock
2014-09-02$9.01/sh−5,000$45,050→ 209,439 total
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 Plan
- [F2]Shares and stock price represented were impacted by a 1 for 100 reverse stock split which occurred on August 28, 2014
- [F3]This transaction was executed in multiple trades at prices ranging from $8.00 to $8.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the full information regarding the number of shares and prices at which each transaction was effected.